Antimetabolite TTL-315 selectively kills glucose-deprived cancer cells and enhances responses to cytotoxic chemotherapy in preclinical models of cancer.

about

Cell damage produced by magnetic fluid hyperthermia on microglial BV2 cells

P2860

Q41446969-7DD6A450-A7FF-4432-B023-92FF21B38E13

P2860

Antimetabolite TTL-315 selectively kills glucose-deprived cancer cells and enhances responses to cytotoxic chemotherapy in preclinical models of cancer.

Item

http://www.wikidata.org/entity/Q36946508

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Antimetabolite TTL-315 selecti ...... preclinical models of cancer.

@en

type

Item

label

Antimetabolite TTL-315 selecti ...... preclinical models of cancer.

@en

prefLabel

Antimetabolite TTL-315 selecti ...... preclinical models of cancer.

@en

P1476

Antimetabolite TTL-315 selecti ...... preclinical models of cancer.

@en

P2093

George C Prendergast

http://www.w3.org/2001/XMLSchema#string

James DuHadaway

http://www.w3.org/2001/XMLSchema#string

P2860

Mutation in G6PD gene leads to loss of cellular control of protein glutathionylation: mechanism and implication

Metabolic regulation of T cell differentiation and function

Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses

Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease.

Targeted disruption of the housekeeping gene encoding glucose 6-phosphate dehydrogenase (G6PD): G6PD is dispensable for pentose synthesis but essential for defense against oxidative stress

Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice

Radiation response of cells during altered protein thiol redox.

Inhibition of glutathione peroxidase mediates the collateral sensitivity of multidrug-resistant cells to tiopronin

Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging.

Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy.

P304

7372-7380

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.7058

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26840263

http://www.w3.org/2001/XMLSchema#string

P932

4884924

http://www.w3.org/2001/XMLSchema#string

Antimetabolite TTL-315 selectively kills glucose-deprived cancer cells and enhances responses to cytotoxic chemotherapy in preclinical models of cancer.

about

P2860

P2860

Antimetabolite TTL-315 selectively kills glucose-deprived cancer cells and enhances responses to cytotoxic chemotherapy in preclinical models of cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932